Latest Close
$0.37
News
JAGX
Jaguar Health, Inc. News
This news view pulls recent coverage and headlines tied to JAGX.
1y Change
-$5.20 (-93.38%)
Market Cap
$4,582,713.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
Jaguar Health Inc (JAGX) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ...
GuruFocus.com • Apr 11, 2026
Read articleReminder: Jaguar Health to Host Investor Webcast at 8:30 am Eastern on Friday, April 10, 2026 Regarding Q4 2025 Financials and Company Updates
ACCESS Newswire • Apr 10, 2026
Read articleJaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
ACCESS Newswire • Apr 8, 2026
Read articleJaguar Health Reports 2025 Financials
ACCESS Newswire • Apr 7, 2026
Read articleJaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
ACCESS Newswire • Apr 2, 2026
Read articleFDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)
ACCESS Newswire • Mar 18, 2026
Read article